Tag: clinical trial

A Daily Pill Can Prevent HIV Transmission, Two Studies Show

By Valerie Ross | July 15, 2011 11:15 am

What’s the News: A daily dose of anti-HIV drugs can significantly reduce the likelihood that straight men and women will contract HIV from an infected partner, according to two new clinical studies. These studies add strong evidence to earlier findings that taking HIV drugs can prevent healthy people from contracting the disease, and are the first to show that the drugs reliably lower transmission risk in heterosexuals.

Read More

CATEGORIZED UNDER: Health & Medicine

Three New Promising Treatments for Treating Lethal Melanoma

By Valerie Ross | June 7, 2011 2:03 pm

What’s the News: Three new drugs have been shown to improve survival and slow disease progress in patients with metastatic melanoma. This advanced form of the disease is the deadliest type of skin cancer, with patients surviving for an average of only 6 to 9 months. Phase III clinical trials of the treatments—a new chemotherapy drug, an immune-system treatment combined with traditional chemotherapy, and a vaccine combined with another immune treatment—were recently published in the New England Journal of Medicine.

Read More

CATEGORIZED UNDER: Health & Medicine, Top Posts

Deadly E. coli Outbreak Sweeps Europe, Its Source Still a Mystery

By Valerie Ross | June 1, 2011 3:05 pm

What’s the News: A massive outbreak of E. coli is spreading through Europe, with 17 people dead in the last two weeks and 1,500 people sickened in Germany alone, where the outbreak began. Authorities are still trying to figure out where the outbreak originated and how it can be treated.

Read More

CATEGORIZED UNDER: Health & Medicine, Top Posts

Researchers Make Progress Against Cancer by Training Immune Cells Know Their Enemy

By Valerie Ross | April 29, 2011 12:16 pm

melanomaMetastatic melanoma cells

What’s the News: Souped-up cells from a patient’s own immune system could one day be used to treat advanced melanoma, according to a preliminary study published in Science Translational Medicine investigating the safety of the technique. The researchers manipulated a patient’s immune system cells to better recognize cancer cells in the lab and then re-introduced those cells into the body—an approach called “adoptive T-cell therapy.”

Read More

CATEGORIZED UNDER: Health & Medicine
NEW ON DISCOVER
OPEN
CITIZEN SCIENCE
ADVERTISEMENT

Discover's Newsletter

Sign up to get the latest science news delivered weekly right to your inbox!

80beats

80beats is DISCOVER's news aggregator, weaving together the choicest tidbits from the best articles covering the day's most compelling topics.
ADVERTISEMENT

See More

ADVERTISEMENT
Collapse bottom bar
+

Login to your Account

X
E-mail address:
Password:
Remember me
Forgot your password?
No problem. Click here to have it e-mailed to you.

Not Registered Yet?

Register now for FREE. Registration only takes a few minutes to complete. Register now »